Stay updated on Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial

Sign up to get notified when there's something new on the Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    A new revision label 'Revision: v3.6.6' appears on the page, replacing the previous 'Revision: v3.6.5'. This indicates a minor page deployment update and does not change the study content or its presented details.
    Difference
    0.0%
    Check dated 2026-08-31T18:26:46.000Z thumbnail image
  4. Check
    21 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page's revision label in the footer was updated from v3.6.4 to v3.6.5, indicating a minor update to the page or its underlying system. It does not alter visible content or how users interact with the study details.
    Difference
    0.0%
    Check dated 2026-08-10T13:01:11.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4. This reflects a new release version and does not change study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-07-27T06:23:01.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Revision updated from v3.6.2 to v3.6.3, indicating a post-release update to the study record.
    Difference
    0.0%
    Check dated 2026-07-05T13:37:38.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    A minor page software/UI update updated the revision from v3.6.0 to v3.6.2, with no evident changes to the study content or participant information.
    Difference
    0.0%
    Check dated 2026-06-28T08:40:23.000Z thumbnail image
  9. Check
    86 days ago
    Change Detected
    Summary
    Removed sponsor-related branding and multiple study-support resources from the Study Details page, including the Investigator Inquiry form and various helpful links and documents; this alters how users can contact investigators and access trial materials.
    Difference
    0.3%
    Check dated 2026-06-21T02:16:05.000Z thumbnail image

Stay in the know with updates to Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial page.